| 28.79 0.11 (0.38%) | 07-26 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 34.09 | 1-year : | 39.82 |
| Resists | First : | 29.19 | Second : | 34.09 |
| Pivot price | 27.5  |
|||
| Supports | First : | 26.72 | Second : | 25.2 |
| MAs | MA(5) : | 28.62 |
MA(20) : | 27.13 |
| MA(100) : | 28.05 |
MA(250) : | 28.31 |
|
| MACD | MACD : | 0.5 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 91 |
D(3) : | 91.8 |
| RSI | RSI(14): 71.3 |
|||
| 52-week | High : | 31.65 | Low : | 25.2 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ RPRX ] has closed below upper band by 21.8%. Bollinger Bands are 125.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 29.09 - 29.17 | 29.17 - 29.27 |
| Low: | 28.43 - 28.53 | 28.53 - 28.65 |
| Close: | 28.6 - 28.76 | 28.76 - 28.94 |
Wed, 24 Jul 2024
RPRX - Royalty Pharma plc Latest Stock News & Market Updates - StockTitan
Wed, 24 Jul 2024
Should You Consider Adding Royalty Pharma plc (RPRX) to Your Portfolio? - Yahoo Finance UK
Wed, 24 Jul 2024
Royalty Pharma Appoints Molly Sawaya as Executive Vice President, Head of Human Capital - StockTitan
Tue, 23 Jul 2024
Vanguard Group Inc. Lowers Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - Defense World
Tue, 23 Jul 2024
Vanguard Group Inc. Has $1.14 Billion Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Tue, 23 Jul 2024
Intech Investment Management LLC Makes New $386,000 Investment in Royalty Pharma plc (NASDAQ:RPRX) - Defense World
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 452 (M) |
| Shares Float | 389 (M) |
| Held by Insiders | 13.4 (%) |
| Held by Institutions | 71.8 (%) |
| Shares Short | 16,900 (K) |
| Shares Short P.Month | 13,250 (K) |
| EPS | 1.77 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 14.4 |
| Profit Margin | 35.6 % |
| Operating Margin | -13 % |
| Return on Assets (ttm) | 3.5 % |
| Return on Equity (ttm) | 12 % |
| Qtrly Rev. Growth | -17 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 4.95 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -98.6 % |
| Operating Cash Flow | 2,620 (M) |
| Levered Free Cash Flow | -1,130 (M) |
| PE Ratio | 16.17 |
| PEG Ratio | 2.2 |
| Price to Book value | 1.99 |
| Price to Sales | 5.81 |
| Price to Cash Flow | 4.96 |
| Dividend | 0.2 |
| Forward Dividend | 0 |
| Dividend Yield | 0.7% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|